Otros idiomas PharmAust Limited

Acciones

PAA

AU000000PAA1

Mercado cerrado - Australian S.E. Otros sitios de cotización 08:10:46 10/05/2024			Varia. Cinco días.	Varia. 1 de enero.
0,17 ^AUD	-5,56 %		-22,73 %	+47,83 %

09/05	Pharmaust nombra presidente interino y director gerente; las acciones caen un 16	MT
10/04	PharmAust obtiene la aprobación para iniciar un estudio de extensión del monepantel	MT

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Pharmaust Appoints Interim Chair, Managing Director; Shares Fall 16%	09/05
Pharmaust CEO Resigns	23/04
PharmAust Obtains Approval to Commence Monepantel Extension Study	10/04
PharmAust Retracts CEO Statement from Media	02/04
PharmAust Submits Supporting Data to US FDA for Monepantel Orphan Drug Designation Request; Shares Down 7%	14/03
PharmAust Limited Reports Earnings Results for the Half Year Ended December 31, 2023	29/02
PharmAust advances monepantel for motor neurone disease towards FDA approval	28/02
PharmAust Gets US FDA Guidance for Motor Neuron Disease Medication	16/02
PharmAust Appoints Non-Executive Director	07/02
PharmAust Secures Ethics Approval for Phase One Motor Neuron Disease Extension Study; Shares Rise 6%	30/01
PharmAust to Amend Monepantel Orphan Drug Designation Request to FDA	29/01
PharmAust Ties Up with Berry Consultants for Upcoming Phase 2/3 Motor Neuron Disease Trial; Shares Rise 4%	16/01
PharmAust Secures Meeting with US FDA for Motor Neuron Disease Drug Application; Shares Jump 9%	02/01
PharmAust Secures Support for Phase 2/3 Clinical Trial Grant Request	26/12
PharmAust Secures R&D Tax Refund for Fiscal Year 2023	20/12
PharmAust Achieves 93% take Up on Options Offer	15/12
PharmAust to Raise AU$3.5 Million From Share Sale	14/12
PharmAust Concludes Phase One Study for Motor Neuron Disease Medication	01/12
Pharmaust Completes Dosing for All Cohort Four Patients in Phase One Study of Motor Neurone Disease; Shares Rise 3%	13/10/23
PharmAust Limited Reports Earnings Results for the Full Year Ended June 30, 2023	31/08/23

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas PharmAust Limited

Acciones

PAA

AU000000PAA1

Otros idiomas

Filtros